Clinical Trial Update: Study to Assess SLN124 in Patients With Polycythemia Vera [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SLN124 in Polycythemia vera reports ongoing Phase 1/Phase 2 evaluation. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• SLN124

Snippet

Sponsor: Silence Therapeutics plc | Conditions: Polycythemia Vera | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING